# Stoke Therapeutics, Inc. (STOK)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/STOK/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 188.83M | $ -7.05M | $ 45.99M | $ 0 | $ 352.46M |
| 2024 | $ 38.42M | $ -93.53M | $ -91.50M | $ 2.32M | $ 229.02M |
| 2023 | $ 9.49M | $ -113.21M | $ -89.40M | $ 2.06M | $ 159.57M |
| 2022 | $ 13.86M | $ -112.90M | $ -40.02M | $ 2.36M | $ 184.85M |
| 2021 | $ 0 | $ -101.99M | $ -80.96M | $ 1.51M | $ 217.78M |
| 2020 | $ 0 | $ -66.55M | $ -55.12M | $ 1.07M | $ 286.08M |
| 2019 | $ 0 | $ -41.72M | $ -42.19M | $ 0 | $ 224.43M |
| 2018 | $ 0 | $ -16.54M | $ -15.71M | $ 0 | $ 105.07M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.19 |
| Current Ratio | 5.28 |

## Other views

- [Metrics](https://sponda.capital/en/STOK.md)
- [Charts](https://sponda.capital/en/STOK/charts.md)
- [Compare](https://sponda.capital/en/STOK/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.